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Abstract: A personal selection of 32 recent papers is presented covering various 
aspects of current developments in bioorganic chemistry and novel natural products 
such as huperphlegmine A from Huperzia phlegmaria. 
 
The structure of citrofulvicin 1, a racemic metabolite from Penicillium velutinum, was 
confirmed by X-ray analysis.1 It is proposed that the unprecedented framework of 
citrofulvicin 1 is formed by nonenzymatic Diels-Alder cycloaddition between 
heptaketide precursors. The structure of asperone A 2, a metabolite of Aspergillus sp. 
AWG 1-15, was established by X-ray analysis of a methylated derivative.2 A 
biosynthetic pathway to asperone A 2, involving two polyketide precursors, has been 
suggested. The structure of tsavoenone A 3, from the lichen Parmotrema tsavoense, 
was also established by X-ray anlysis.3 A putative biosynthetic scheme for the 
formation of tsavoenone A 3 from a depsidone precursor, parmosidone D, has been 
presented. 
 
 
The insect-borne fungus Mucor sp. SNB-VECD13A produces mucorolactone 4 with a 
novel macrolactone skeleton that may be derived from linoleic acid.4 Activation of a 
silent biosynthetic gene cluster in Streptomyces roseosporus produces a polyketide 
macrolactam, auroramycin 5, that shows potent antibiotic activity.5 Auroramycin 5 
contains an unusual isobutyl extender unit and a novel disaccharide. 
 
Four highly oxygenated p-terphenyl derivatives, including hawaiienol A 6, have been 
identified as metabolites of the insect-associated fungus Paraconiothyrium 
hawaiiense.6 Hawaiienol A 6 is the first example of a terphenyl with a 4,7-
dioxatricyclo[3.2.1.03,6]octane unit and its structure and absolute configuration were 
determined by X-ray analysis. Further unusual natural products whose structures have 
been confirmed by X-ray analyses include cleistoperlones A 7 and C 8, from 
Cleistocalyx operculatus,7 and eucalyptusdimer A 9, from Eucalyptus robusta.8 
Cleistoperlone A 7 is formed from two cinnamylphloroglucinol units and 
cleistoperlone C 8, from a cinnamylphloroglucinol unit with α-pinene. 
Eucalyptusdimer A 9 has an unprecedented skeleton featuring two phelandrene and 
two acylphloroglucinol units. Biosynthetic pathways have been proposed for 
cleistoperlones A 7 and C 8 and eucalyptusdimer A 9. 
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A rearranged isopimarane diterpenoid derivative featuring a fused cyclobutane ring, 
eutypellenone A 10, is a metabolite of Eutypella sp. D-1.9 The authors claim that 
eutypellenone A 10 belongs to the opposite entantiomeric series as the cometabolite 
libertellenone H 11. Salvifarinin A 12, from Salvia farinacea, has a cyclised and 
rearranged clerodane skeleton.10 The authors propose a biosynthetic pathway to 
salvifarinin A 12 which is supported by a biomimetic synthesis. Mangelonoid A 13, 
from Croton mangelong, has a novel 2,20-cyclocembrane diterpenoid skeleton.11 The 
structures of salvifarinin A 12 and mangelonoid A 13 were confirmed by X-ray 
analyses. Four eremophilane sesquiterpenoid dimers and trimers, such as ligusaginoid 
A 14, have been isolated from Ligularia sagitta.12 A biosynthetic pathway to 
ligusaginoid A 14 has been proposed involving two Diels-Alder cycloadditions. 
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Huperphlegmine A 15, from Huperzia phlegmaria,13 and erchinine A 16, from 
Ervatamia chinensis,14 have new alkaloid skeletons. Biosynthetic pathways from 
obscurinine to huperphlegmine A 15 and from ibogaine to erchinine A 16 have been 
proposed. The structure of the racemic spirocyclic diketopiperazine valiecolortin A 
17, from the marine-derived fungus Eurotium sp. SCSIO F452, was established by X-
ray analysis.15 A biosynthetic pathway to the novel skeleton of valiecolortin A 17 has 
been suggested involving a hetero-Diels-Alder cyloaddition of a diketopiperazine 
with an anthraquinone and a Baeyer-Villiger oxidation as key steps. 
Isatindolignanoside A 18, from roots of Isatis indigotica, is the first report of an 
indole linked to a lignan.16 The authors propose a biosynthetic pathway to 
isatindolignanoside A 18. 
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Feeding studies have been used to investigate the biosynthesis of strobilurins (e.g. 
strobilurin B 19), antifungal metabolites isolated from various basidiomycetes.17 
These studies have shown that the stobilurins are formed from a linear tetraketide and 
a benzoate starter unit, which is produced from phenylalanine via cinnamate. The 
isolation of a novel biphenyl metabolite, pseudostrobilurin B confirmed the 
involvement of an epoxide intermediate during the formation of the β-
methoxyacrylate moiety. Disruption of LaeB, a global regulator from Aspergillus 
nidulans has allowed activation of secondary metabolism and the isolation of eight 
cryptic compounds.18 These include seven polyketides such as 3-methoxyporriolide 
20, an optically active phthalide. 
 
Genome mining in Pseudomonas and overexpression of the Pseudomonas virulence 
factor (pvf) gene cluster has allowed the isolation of a family of pyrazine N-oxides, 
including the novel dihydropyrazine N,N’-dioxide 21.19 Following characterisation of 
the nonribosomal peptide synthetase (NRPS) responsible for the formation of these 
compounds, a biosynthetic pathway from valine has been proposed. The biosynthetic 
gene cluster from the myxobacterium Cystobacter violaceus Cb vi35 that produces 
vioprolides (e.g. vioprolide C 22), anticancer and antifungal compounds has been 
identified.20 As well as the expression of the gene cluster in a stable heterologous 
host, which allowed high-titre production of these compounds, further studies 
revealed an S-adensoylmethionine (SAM)-dependent enzyme and a methyltransferase 
involved in the formation of the 4-methylazetidinecarboxylic acid moiety. 
 
Genome sequencing and bioinformatics analysis has identified the biosynthetic gene 
cluster of antimycin-type depsipeptides from Streptomyces conglobatus such as 
neoantimycin A 23, which have significant anticancer activities.21 Heterologous 
expression of the partial gene cluster in Streptomyces albus J1074 led to the 
production of 23, while bioengineering revealed an NADPH-dependent reductase 
responsible for formation of the C-1 hydroxyl. A unique NRPS-polyketide synthase 
hybrid gene cluster from Sulfurospirillum barnesii has been analysed and following 
gene expression and comparative metabolomics, led to the isolation of the lipo-
dipeptide, barnesin A 24.22 The structure of barnesin A 24 was confirmed by total 
synthesis and the compound was found to have antimicrobial activity, as well as being 
a selective inhibitor of cathepsin B. 
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Further characterisation of the biosynthetic gene cluster from Streptomyces sp. 
SoC090715LN-17, that produces s56-p1 25, a dipeptide with a unique hydrazine unit 
has allowed the characterisation of three new enzymes.23 A combination of in vivo 
and in vitro experiments has shown that these enzymes cooperate to form the 
hydrazinoacetic acid component of s56-p1. Genome mining and analysis of 
Paraburkholderia graminis has led to the characterisation of gramibactin 26, an iron 
binding lipodepsipeptide.24 NMR spectroscopy and in particular, complexation-
induced chemical shifts were used to show that the N-nitrosohydroxylamine moieties 
are involved in metal binding. 
 
 Three homologous cytochrome P450 enzymes from three indole alkaloid-producing 
plants have been discovered and shown to allow entry to two distinct classes of 
alkaloids, the sarpagans (e.g. vinorine 27) and the β-carbolines.25 These results reveal 
via a common mechanism, how distinct substrates lead to either a cyclisation or 
aromatisation process. The biosynthetic pathway of marinone and naphterpin natural 
products such as naphthgeranine A 28 have been shown to involve a cryptic 
halogenation, mediated by vanadium-dependent chloroperoxidase (VCPO) enzymes.26 
The VCPO-catalysed transformation involves a dearomatisation and dichlorination, 
followed by an α-hydroxyketone rearrangement and loss of chloride anion leaving 
groups, resulting in the highly oxidised naphthoquinone core. 
 
An artificial enzyme that has the ability to catalyse hydrazine (Scheme 1) and oxime 
formation has been created.27 Introduction of the catalytically active p-
aminophenylalanine into a promiscuous binding pocket of the multidrug 
transcriptional regulator from Lactococcus lactis results in a designer enzyme that can 
outperform other catalysts such as aniline. Heterologous expression of four enzymes 
(tpcA–D) in Aspergillus oryzae has allowed the total biosynthesis of the sesterterpene, 
(–)-terpestacin 29.28 Following formation of preterpestacin I 30 by terpene synthase 
TpcA, three hydroxyl groups are introduced by two cytochrome P450 enzymes 
(TpcB/C) (Scheme 2). The process is then completed by the flavin-dependent oxidase 
TpcD, which catalyses oxidation of a diol unit to generate (–)-terpestacin 29. 
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The first biocatalytic deracemisation of sulfoxides has been achieved using a 
combination of an oxaziridine-type oxidant and the highly enantioselective 
methionine sulfoxide reductase A (MsrA).29 A biphasic system was used in which 
MSrA performs a kinetic resolution, forming a sulfide that is oxidised back to the 
sulfoxide by the oxaziridine-based lipophilic oxidant (Scheme 3). Overall, the process 
showed a wide substrate scope, producing optically active sulfoxides with excellent 
enantioselectivity. A combination of air as the terminal oxidant and an engineered 
Baeyer-Villiger monooxygenase (BVMO) has been used for the preparation of the 
chiral sulfoxide, esomeprazole 31, the S-enantiomer and active pharmaceutical 
ingredient of the blockbuster drug Nexium.30 By directed evolution, the resulting 
engineered BVMO mediated-process provides an alternative to the Kagan 
chemocatalytic oxidation, producing esomeprazole in 87% yield and in >99% 
enantiomeric excess (Scheme 4). 
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A self-sufficient protein, OleT-BM3R, formed from the fusion of the decarboxylase 
OleTJE and the reductase domain of P450BM3 has been shown to catalyse the 
oxidative decarboxylation of carboxylic acids to form linear α-olefins.31 The 
engineered fusion protein uses oxygen as the oxidant and NADPH as the electron 
donor, and in combination with a phosphite dehydrogenase-based NADPH 
regeneration system (Scheme 5), gave product titres of up to 2.51 g L–1. A quinolone-
based two-photon fluorescent probe 32 has been developed for the ratiometric 
detection and imaging of hypochlorous acid (HClO).32 In response to HClO, the probe 
shows a decrease in blue emission with a concurrent increase of green emission and 
was used for detecting exogenous and endogenous HClO in living cells. 
 References 
 
1 Y. Chen, N. Jiang, Y. J. Wei, X. Li, H. M. Ge, R. H. Jiao and R. X. Tan, Org. Lett., 
2018, 20, 3741. 
2 G.-P. Yin, Y.-R. Wu, C. Han, X.-B. Wang, H.-L. Gao, Y. Yin, L.-Y. Kong and M.-
H. Yang, Org. Chem. Front., 2018, 5, 2432. 
3 T.-H. Duong, M. A. Beniddir, G. Genta-Jouve, T. Aree, M. Chollet-Krugler, J. 
Boustie, S. Ferron, A. Sauvager, H.-H. Nguyen, K.-P.-P. Nguyen, W. Chavasiri and P. 
L. Pogam, Org. Biomol. Chem., 2018, 16, 5913. 
4 S. Touré, M. Barthélémy, J. Sorres, G. Genta-Jouve, I. Dusfour, V. Eparvier and D. 
Stien, Org. Lett., 2018, 20, 3780. 
5 Y. H. Lim. F. T. Wong, W. L. Yeo, K. C. Ching, Y. W. Lim, E. Heng, S. Chen, D.-
J. Tsai, T.-L. Lauderdale, K.-S. Shia, Y. S. Ho, S. Hoon, E. L. Ang, M. M. Zhang and 
H. Zhao, ChemBioChem, 2018, 19, 1716. 
6 F. Ren, S. Chen, Y. Zhang, S. Zhu, J. Xiao, X. Liu, R. Su and Y. Che, J. Nat. Prod., 
2018, 81, 1752. 
7 J.-C. Su, S. Wang, W. Cheng, X.-J. Huang, M.-M. Li, R.-W. Jiang, Y.-L. Li, L. 
Wang, W.-C. Ye and Y. Wang, J. Org. Chem., 2018, 83, 8522. 
8 X.-J. Qin, M.-Y. Feng, H. Liu, W. Ni, T. Rauwolf, J. A. Porco, Jr., H. Yan, L. He 
and H.-Y. Liu, Org. Lett., 2018, 20, 5066. 
 
 9 H.-B. Yu, X.-L. Wang, Y.-X. Zhang, W.-H. Xu, J.-P. Zhang, X.-Y. Zhou, X.-L. Lu, 
X.-Y. Liu and B.-H. Jiao, J. Nat. Prod., 2018, 81, 1553. 
10 M. Fan, X.-J. Chen, X.-D. Wu, L.-D. Shao, X. Ji and Q.-S. Zhao, Tetrahedron 
Lett., 2018, 59, 3065. 
11 W.-Y. Zhang. J.-X. Zhao, L. Sheng, Y.-Y. Fan, J.-Y. Li, K. Gao and J.-M. Yue, 
Org. Lett., 2018, 20, 4040. 
12 H.-Y. Li, Z.-Q. Zheng, W.-J. Wei, J.-J. Chen and K. Gao, Tetrahedron Lett., 2018, 
59, 3461. 
13 H. T. Nguyen, H. T. Doan, D. V. Ho, K. T. Pham, A. Raal and H. Morita, 
Fitoterapia, 2018, 129, 267. 
14 H.-F. Yu, X.-J. Qin, C.-F. Ding, X. Wei, J. Yang, J.-R. Luo, L. Liu, A. Khan, L.-C. 
Zhang, C.-F. Xia and X.-D. Luo, Org. Lett., 2018, 20, 4116. 
15 W. Zhong, J. Wang, X. Wei, Y. Chen, T. Fu, Y. Xiang, X. Huang, X. Tian, Z. 
Xiao, W. Zhang, S. Zhang, L. Long and F. Wang, Org. Lett., 2018, 20, 4593. 
16 L. Meng, Q. Guo, M. Chen, J. Jiang, Y. Li and J. Shi, Chin. Chem. Lett., 2018, 29, 
1257. 
17 Z. Iqbal, L.-C. Han, A. M. Soares-Sello, R. Nofiani, G. Thormann, A. Zeeck, R. J. 
Cox, C. L. Willis and T. J. Simpson, Org. Biomol. Chem., 2018, 16, 5524. 
18 H. Lin, H. Lyu, S. Zhou, J. Yu, N. P. Keller, L. Chen and W.-B. Yin, Org. Biomol. 
Chem., 2018, 16, 4973. 
19 A. M. Kretsch, G. L. Morgan, J. Tyrrell, E. Mevers, I. Vallet-Gély and B. Li, Org. 
Lett., 2018, 20, 4791. 
20 F. Yan, D. Auerbach, Y. Chai, L. Keller, Q. Tu, S. Hüttel, A. Glemser, H. A. Grab, 
T. Bach, Y. Zhang and R. Müller, Angew. Chem. Int. Ed., 2018, 57, 8754. 
 
 21 Y. Zhou, X. Lin, S. R. Williams, L. Liu, Y. Shen, S.-P. Wang, F. Sun, S. Xu, H. 
Deng, P. F. Leadlay and H.-W. Lin, ACS Chem. Biol., 2018, 13, 2153. 
22 M. Rischer, L. Raguž, H. Guo, F. Keiff, G. Diekert, T. Goris and C. Beemelmanns, 
ACS Chem. Biol., 2018, 13, 1990. 
23 K. Matsuda, T. Tomita, K. Shin-ya, T. Wakimoto, T. Kuzuyama and M. 
Nishiyama, J. Am. Chem. Soc., 2018, 140, 9083. 
24 R. Hermenau, K. Ishida, S. Gama, B. Hoffmann, M. Pfeifer-Leeg, W. Plass, J. F. 
Mohr, T. Wichard, H.-P. Saluz and C. Hertweck, Nat. Chem. Biol., 2018, 14, 841. 
25 T.-T. T. Dang, J. Franke, I. Soares, T. Carqueijeiro, C. Langley, V. Courdavault 
and S. E. O’Connor, Nat. Chem. Biol., 2018, 14, 760. 
26 L. A. M. Murray, S. M. K. McKinnie, H. P. Pepper, R. Erni, Z. D. Miles, M. C. 
Cruickshank, B. López-Pérez, B. S. Moore and J. H. George, Angew. Chem. Int. Ed., 
2018, 57, 11009. 
27 I. Drienovská, C. Mayer, C. Dulson and G. Roelfes, Nat. Chem., 2018, 10, 946. 
28 K. Narita, A. Minami, T. Ozaki, C. Liu, M. Kodama and H. Oikawa, J. Org. 
Chem., 2018, 83, 7042. 
29 V. Nosek and J. Míšek, Angew. Chem. Int. Ed., 2018, 57, 9849. 
30 Y. K. Bong, S. Song, J. Nazor, M. Vogel, M. Widegren, D. Smith, S. J. Collier, R. 
Wilson, S. M. Palanivel, K. Narayanaswamy, B. Mijts, M. D. Clay, R. Fong, J. 
Colbeck, A. Appaswami, S. Muley, J. Zhu, X. Zhang, J. Liang and D. Entwistle, J. 
Org. Chem., 2018, 83, 7453. 
31 C. Lu, F. Shen, S. Wang, Y. Wang, J. Liu, W.-J. Bai and X. Wang, ACS Catal., 
2018, 8, 5794. 
 
 32 Z. Mao, M. Ye, W. Hu, X. Ye, Y. Wang, H. Zhang, C. Li and Z. Liu, Chem. Sci., 
2018, 9, 6035. 
